Predictive value of CHFR and MLH1 methylation in human gastric cancer

Yazhuo Li(Chinese PLA General Hospital), Mingzhou Guo(Chinese PLA General Hospital), Youyong Lu(Peking University), James G. Herman(UPMC Hillman Cancer Center), Po Zhao(Chinese PLA General Hospital), Yunsheng Yang(Chinese PLA General Hospital), Malcolm V. Brock(Johns Hopkins University)
Gastric Cancer
April 20, 2014
10.1007/s10120-014-0370-2
Cited by 76

Related Papers

Inactivation of the DNA-Repair Gene<i>MGMT</i>and the Clinical Response of Gliomas to Alkylating Agents
|New England Journal of Medicine|2000|2.2k
Incidence and functional consequences of <i>hMLH1</i> promoter hypermethylation in colorectal carcinoma
|Proceedings of the National Academy of Sciences|1998|1.9k
Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer
|Cancer Discovery|2016|897
Correlation of O<sup>6</sup>-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity
|Journal of Clinical Oncology|2008|805
SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity
|Nature Genetics|2001|734